Journal
MOLECULAR NEURODEGENERATION
Volume 4, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1750-1326-4-48
Keywords
-
Categories
Funding
- European Community [FP7/2007-2013, 200611]
- NIH [1R01AG027443]
Ask authors/readers for more resources
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. Accordingly, it has been proposed that synapse loss underlies the memory impairment evident in the early phase of AD and that since plasticity is important for neuronal viability, persistent disruption of plasticity may account for the frank cell loss typical of later phases of the disease. Extensive multi-disciplinary research has implicated the amyloid beta-protein (A beta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of A beta are mediators of synaptic compromise. We also discuss the possible mechanisms of A beta synaptotoxicity and potential targets for therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available